IBM Research and CiQUS scientists first to image short-lived molecules

Top story

English | German

Zurich, Switzerland, and Santiago de Compostela, Spain, 13 July 2015—Scientists from IBM Research (NYSE: IBM) and CIQUS at the University of Santiago de Compostela, Spain, have confirmed the existence and characterized the structure of arynes, a family of highly reactive, short-lived molecules that was first suggested 113 years ago. The technique has broad applications for on-surface chemistry and electronics, including the preparation of graphene nanoribbons and novel single-molecule devices.

Short-lived molecules
There are trillions of molecules in the universe and some of them are stable enough to be isolated and characterized, but many others are so short-lived that they can only be proposed indirectly via chemical reactions or spectroscopic methods.

One such species are arynes, which were first suggested in 1902, and since then have been used as intermediates or building blocks to synthesize a variety of compounds for applications including medicine, organic electronics and molecular materials. The challenge with these particular molecules is that they only exist for several milliseconds, making them extremely difficult to image. Until now.

Today the peer-reviewed journal Nature Chemistry has published the imaging of a single aryne molecule for the first time. This work is the result of a joint effort by CiQUS researchers in Santiago, who are experts in aryne chemistry, and the IBM team in Zurich, who have developed new atomic-resolution microscopy techniques.


“Arynes are discussed in almost every undergraduate course on organic chemistry around the world. Therefore, it’s kind of a relief to have finally confirmed that these molecules truly exist,” said Prof. Diego Peña, a chemist at the University of Santiago de Compostela. “I look forward to seeing new chemical challenges solved by the combination of organic synthesis and AFM.”

After the preparation of the key aryne precursor by CiQUS, IBM scientists used the sharp tip of a scanning tunneling microscope (STM) to generate individual aryne molecules from precursor molecules by atomic manipulation. The experiments were performed on films of sodium chloride at temperatures near absolute zero to stabilize the aryne. Once the molecules were isolated, the team used atomic force microscopy (AFM) to measure the tiny forces between the tip, which is terminated with a single carbon monoxide molecule, and the sample to image the aryne’s molecular structure. The resulting image was so clear that the scientists were able to study their chemical nature based on the minute differences between individual bonds.

“The IBM team has developed several state-of-the-art techniques since 2009 that made this achievement possible,” said Dr. Niko Pavliček, a physicist at IBM Research. “For this study it was absolutely essential to pick an insulating film on which the molecules were adsorbed and to deliberately choose the atomic tip-terminations to probe them. We hope this technique will have profound effects on the future of chemistry and electronics.”

This work is a result of the large European project called PAMS (Planar Atomic and Molecular Scale Devices). PAMS’ main objective is to develop and investigate novel electronic devices of nanometric-scale size. Part of this research is funded by a European Research Council Advanced Grant awarded to IBM scientist Dr. Gerhard Meyer, who is also a co-author of the paper. These prestigious grants support “the very best researchers working at the frontiers of knowledge” in Europe.

IBM Research and CiQUS have previously collaborated and published papers on differentiating the chemical bonds in individual molecules and imaging high-quality nanographenes generated from easily available organic compounds.

This research is part of IBM’s five-year, $3 billion investment to push the limits of chip technology and semiconductor innovations needed to meet the emerging demands of cloud computing and Big Data systems.

The results of this research also reinforce one the main research lines of CIQUS, which is devoted to developing bottom-up approaches to molecular-scale electronics.

The STM and its offspring the AFM are the two workhorses of atomic and molecular-scale research. The STM, which was invented by Gerd Binnig and Heinrich Rohrer at IBM Research – Zurich in 1981, allowed scientists for the first time to image individual atoms on a surface. The revolutionary microscope, for which the two scientists received the 1986 Nobel Prize in physics, has expanded the boundaries of our knowledge by revealing the properties of surfaces and molecules or atoms adsorbed thereon with atomic resolution.

About IBM Research

Now in its 70th year, IBM Research continues to define the future of technology with more than 3,000 researchers in 12 labs located across six continents. IBM Research breakthroughs helped the company achieve an industry record of 7,534 patents in 2014, marking the 22nd consecutive year that IBM has topped the annual list of U.S. patent recipients. Scientists from IBM Research have produced six Nobel laureates, 10 U.S. National Medals of Technology, five U.S. National Medals of Science, six Turing Awards, 19 inductees into the National Academy of Sciences and 20 inductees into the U.S. National Inventors Hall of Fame.


The Center for Research in Biological Chemistry and Molecular Materials (CiQUS) was founded by University of Santiago de Compostela (USC) in 2011. The mission of CIQUS is to achieve cutting-edge, multidisciplinary research at the interface of chemistry, biomedicine and molecular materials. With 35 principal researchers, some 30 postdocs and more than 100 graduate students, CIQUS' research ranges from basic studies on biomolecular and supramolecular chemistry to more applied research for developing new functional materials with potential technological or biological applications.

Press contact

Chris Sciacca
Media Relations
IBM Research - Zurich
Tel +41 44 724 84 43

[an error occurred while processing this directive]
[an error occurred while processing this directive]
[an error occurred while processing this directive]